Tadalafil
Product Images NDC 71610-303

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 71610-303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (30ee4705 36a5 4a56 852d 9d76c40668db 01)

FDA Label Image

Figure 1 (30ee4705 36a5 4a56 852d 9d76c40668db 02)

FDA Label Image

Figure 2 (30ee4705 36a5 4a56 852d 9d76c40668db 03)

This appears to be a chart or graph showing the effects of Tadalafil and doxazosin on standing and supine systolic blood pressure (mmHg) over time post-dose (in hours). It is not possible to derive any further information or context from this text alone.*

FDA Label Image

Figure 3 (30ee4705 36a5 4a56 852d 9d76c40668db 04)

Not available.*

FDA Label Image

Figure 4 (30ee4705 36a5 4a56 852d 9d76c40668db 05)

This is a chart displaying the plasma concentration of Tadalafil in ug/L over time in hours. It compares the concentration levels after a single 20-mg and 5-mg dose of Tadalafil, as well as a once-daily 5-mg dose after 5 consecutive days of administration.*

FDA Label Image

Figure 5 (30ee4705 36a5 4a56 852d 9d76c40668db 06)

FDA Label Image

Figure 6 (30ee4705 36a5 4a56 852d 9d76c40668db 07)

The text describes the change in IPSS Total Score from the baseline after the use of Tadalafil 5 mg compared to placebo. There was a statistically significant difference in the IPSS Total Score between the two groups. The graph shows the change over time (4, 8, and 12 weeks) from the start of treatment.*

FDA Label Image

Figure 7 (30ee4705 36a5 4a56 852d 9d76c40668db 08)

FDA Label Image

Figure 8 (30ee4705 36a5 4a56 852d 9d76c40668db 09)

This text describes the change in IPSS Total Score with Tadalafil 5mg compared to Placebo over a 12-week treatment period, showing a statistically significant difference (*p<0.01).*

FDA Label Image

Torrent Logo (30ee4705 36a5 4a56 852d 9d76c40668db 10)

FDA Label Image

Torrent Logo-pi (30ee4705 36a5 4a56 852d 9d76c40668db 11)

FDA Label Image

Bottle Label 20 mg (71610 0303 04)

FDA Label Image

Aphena Pharma Solutions (TN)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.